ALDEYRA THERAPEUTICS, INC. (ALDX) Operating income 2016–2025
ALDEYRA THERAPEUTICS, INC. (ALDX) annual operating income history from SEC filings — each fiscal year as reported.
-$35.3MFY2025 · since FY2016: -$18.7M → -$35.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.3M | +41.3% |
| FY2024 | -$60.1M | -40.5% |
| FY2023 | -$42.8M | +31.7% |
| FY2022 | -$62.7M | -11.5% |
| FY2021 | -$56.2M | -54.4% |
| FY2020 | -$36.4M | +42.3% |
| FY2019 | -$63.1M | -58.9% |
| FY2018 | -$39.7M | -76.5% |
| FY2017 | -$22.5M | -20.3% |
| FY2016 | -$18.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice